Publications by authors named "Rim Trad"

Claim this Profile
C
CAR-T cells targeting IL-1RAP produced in a closed semiautomatic system are ready for the first phase I clinical investigation in humans.
Clémentine Nicod, Mathieu Neto da Rocha, Walid Warda, Xavier Roussel, Rafik Haderbache, Rim Trad

Curr Res Transl Med· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coated recombinant target protein helps explore IL-1RAP CAR T-cell functionality in vitro.
Mathieu Neto Da Rocha, Melanie Guiot, Clementine Nicod, Rim Trad, Lucie Bouquet

Immunol Res· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chimeric antigen receptor T-cells targeting IL-1RAP: a promising new cellular immunotherapy to treat acute myeloid leukemia.
Rim Trad, Walid Warda, Vincent Alcazer, Mathieu Neto da Rocha, Ana Berceanu

J Immunother Cancer· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Droplet digital PCR allows vector copy number assessment and monitoring of experimental CAR T cells in murine xenograft models or approved CD19 CAR T cell-treated patients.
Rafik Haderbache, Walid Warda, Eric Hervouet, Mathieu Neto da Rocha, Rim Trad

J Transl Med· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute Myeloid Leukemia: From Biology to Clinical Practices Through Development and Pre-Clinical Therapeutics.
Xavier Roussel, Etienne Daguindau, Ana Berceanu, Yohan Desbrosses, Walid Warda, Rim Trad

Front Oncol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[IL-1RAP as a candidate for CAR T-cells immunotherapy].
Mathieu Neto Da Rocha, Rim Trad, Walid Warda, Rafik Haderbache, Lucie Bouquet

Med Sci (Paris)· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CML Hematopoietic Stem Cells Expressing IL1RAP Can Be Targeted by Chimeric Antigen Receptor-Engineered T Cells.
Walid Warda, Fabrice Larosa, Mathieu Neto Da Rocha, Rim Trad, Eric Deconinck

Cancer Res· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis